Delivery Order SPE2DB22D3301-SPE2DB25FY1BB

Award Date 3/5/25
Potential Completion Date 3/6/25
Potential Value $9.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Chlorothiazide Sodium 500 mg vials. The award amount is $3,739.78 and has an ultimate completion date of March 10, 2025. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price contract type. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $20,169.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of chlorothiazide sodium 500 mg vials, a medication used for various medical conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 9, 2024. It is not designated as a set-aside contract....
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 500 mg vials of the medication Chlorothiazide Sodium, with a total ceiling value of $1,081.14 and a completion date of June 26, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 500 mg vials of the pharmaceutical drug chlorothiazide sodium, with a ceiling value of $3,399.80 and a completion date of May 6, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,175.59, is for the delivery of 4566514787 CHLOROTHIAZIDE SOD 500 MG VIALS. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 22, 2024. The contract is not designated with a set-aside requirement....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,399.80 firm-fixed-price delivery order is for the supply of 500 mg chlorothiazide sodium injection vials. The contract has an ultimate completion date of September 27, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,139.62, is a delivery order for the supply of 4,562,841,156 units of Chlorothiazide Sodium 500 mg vials. The contract has an ultimate completion date of November 17, 2023, and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds...
This federal contract award, SPE2DB20D3103|SPE2DB23FM1E4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorothiazide Sodium 500 mg vials. The $1,030.01 fixed-price delivery order has a completion date of January 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,016.61 firm fixed-price delivery order is for Chlorothiazide Sodium 500 mg Vials, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The federal contract award SPE2DB22D6029|SPE2DB25FLTVX was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,538.40 firm fixed price delivery order is for 4,567,050,039 units of Chlorothiazide Sodium 500 mg vials. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY1BB
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,775.46, is for the delivery of chlorothiazide sodium 500 mg vials. The contract is a firm-fixed-price delivery order, with a period of performance through March 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 7/1/25, 9:25 AM